Loading...
•
Jun 30, 2022
CVRx Q2 2022 Earnings Report
CVRx reported second quarter revenue of $5.0 million, a 61% increase over the prior year. Gross profit was $3.8 million, with a gross margin of 76%. Net loss was $11.1 million, or $0.54 per share.
Key Takeaways
CVRx announced its financial results for the second quarter of 2022, highlighted by a 61% increase in revenue compared to the prior year, driven by growth in the U.S. market. The company also achieved a higher gross margin and received FDA approval for a new programmer and MR conditional labeling for its Barostim device.
Second quarter revenue reached $5.0 million, a 61% increase year-over-year.
U.S. revenue was $3.9 million, representing an 87% increase year-over-year.
Gross profit was $3.8 million, with gross margin improving to 76%.
Net loss was $11.1 million, or $0.54 per share.
CVRx
CVRx
CVRx Revenue by Geographic Location
Revenue by Geographic Location
U.S. Revenue
CapyFin.comEurope Revenue
CapyFin.com Forward Guidance
The Company expects to report total revenue between $5.5 million and $6.0 million for the third quarter of 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income